142 related articles for article (PubMed ID: 28006764)
1. Telomere Dysfunction in Nonalcoholic Fatty Liver Disease and Cryptogenic Cirrhosis.
Laish I; Mannasse-Green B; Hadary R; Biron-Shental T; Konikoff FM; Amiel A; Kitay-Cohen Y
Cytogenet Genome Res; 2016; 150(2):93-99. PubMed ID: 28006764
[TBL] [Abstract][Full Text] [Related]
2. Aneuploidy and asynchronous replication in non-alcholic fatty liver disease and cryptogenic cirrhosis.
Laish I; Mannasse-Green B; Hadary R; Konikoff FM; Amiel A; Kitay-Cohen Y
Gene; 2016 Nov; 593(1):162-166. PubMed ID: 27520584
[TBL] [Abstract][Full Text] [Related]
3. Telomere homeostasis in trophoblasts and in cord blood cells from pregnancies complicated with preeclampsia.
Sukenik-Halevy R; Amiel A; Kidron D; Liberman M; Ganor-Paz Y; Biron-Shental T
Am J Obstet Gynecol; 2016 Feb; 214(2):283.e1-283.e7. PubMed ID: 26321036
[TBL] [Abstract][Full Text] [Related]
4. Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease.
Donati B; Pietrelli A; Pingitore P; Dongiovanni P; Caddeo A; Walker L; Baselli G; Pelusi S; Rosso C; Vanni E; Daly A; Mancina RM; Grieco A; Miele L; Grimaudo S; Craxi A; Petta S; De Luca L; Maier S; Soardo G; Bugianesi E; Colli F; Romagnoli R; Anstee QM; Reeves HL; Fracanzani AL; Fargion S; Romeo S; Valenti L
Cancer Med; 2017 Aug; 6(8):1930-1940. PubMed ID: 28677271
[TBL] [Abstract][Full Text] [Related]
5. Telomere length and telomerase reverse transcriptase mRNA expression in patients with hepatitis C.
Biron-Shental T; Amiel A; Anchidin R; Sharony R; Hadary R; Kitay-Cohen Y
Hepatogastroenterology; 2013 Oct; 60(127):1713-6. PubMed ID: 24634940
[TBL] [Abstract][Full Text] [Related]
6. Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis.
Invernizzi P; Bernuzzi F; Lleo A; Pozzoli V; Bignotto M; Zermiani P; Crosignani A; Battezzati PM; Zuin M; Podda M; Raggi C
Dig Liver Dis; 2014 Apr; 46(4):363-8. PubMed ID: 24378524
[TBL] [Abstract][Full Text] [Related]
7. Telomeres, NAFLD and Chronic Liver Disease.
Donati B; Valenti L
Int J Mol Sci; 2016 Mar; 17(3):383. PubMed ID: 26999107
[TBL] [Abstract][Full Text] [Related]
8. Premature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLD.
Nakajima T; Moriguchi M; Katagishi T; Sekoguchi S; Nishikawa T; Takashima H; Kimura H; Minami M; Itoh Y; Kagawa K; Tani Y; Okanoue T
Liver Int; 2006 Feb; 26(1):23-31. PubMed ID: 16420506
[TBL] [Abstract][Full Text] [Related]
9. Leucocyte telomere shortening is associated with nonalcoholic fatty liver disease-related advanced fibrosis.
Kim D; Li AA; Ahmed A
Liver Int; 2018 Oct; 38(10):1839-1848. PubMed ID: 29797393
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
[TBL] [Abstract][Full Text] [Related]
11. Telomere shortening in intra uterine growth restriction placentas.
Biron-Shental T; Sukenik-Halevy R; Sharon Y; Laish I; Fejgin MD; Amiel A
Early Hum Dev; 2014 Sep; 90(9):465-9. PubMed ID: 25010904
[TBL] [Abstract][Full Text] [Related]
12. Telomere length and hTERT expression in patients with acute myeloid leukemia correlates with chromosomal abnormalities.
Hartmann U; Brümmendorf TH; Balabanov S; Thiede C; Illme T; Schaich M
Haematologica; 2005 Mar; 90(3):307-16. PubMed ID: 15749662
[TBL] [Abstract][Full Text] [Related]
13. Telomerase reverse transcriptase mRNA expression in peripheral lymphocytes of patients with chronic HBV and HCV infections.
Satra M; Dalekos GN; Kollia P; Vamvakopoulos N; Tsezou A
J Viral Hepat; 2005 Sep; 12(5):488-93. PubMed ID: 16108763
[TBL] [Abstract][Full Text] [Related]
14. Associations of TERC Single Nucleotide Polymorphisms with Human Leukocyte Telomere Length and the Risk of Type 2 Diabetes Mellitus.
Al Khaldi R; Mojiminiyi O; AlMulla F; Abdella N
PLoS One; 2015; 10(12):e0145721. PubMed ID: 26720590
[TBL] [Abstract][Full Text] [Related]
15. Telomere Length, Aggregates, and Capture in Cirrhosis.
Laish I; Mari A; Mannasse B; Hadary R; Konikoff FM; Amiel A; Kitay-Cohen Y
Isr Med Assoc J; 2018 May; 20(5):295-299. PubMed ID: 29761675
[TBL] [Abstract][Full Text] [Related]
16. Deoxyribonucleic acid telomere length shortening can predict the incidence of non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Ping F; Li ZY; Lv K; Zhou MC; Dong YX; Sun Q; Li YX
J Diabetes Investig; 2017 Mar; 8(2):174-180. PubMed ID: 27451965
[TBL] [Abstract][Full Text] [Related]
17. High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis.
Leti F; Malenica I; Doshi M; Courtright A; Van Keuren-Jensen K; Legendre C; Still CD; Gerhard GS; DiStefano JK
Transl Res; 2015 Sep; 166(3):304-14. PubMed ID: 26001595
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine accelerates senescence of endothelial cells via DNA hypomethylation of human telomerase reverse transcriptase.
Zhang D; Sun X; Liu J; Xie X; Cui W; Zhu Y
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):71-8. PubMed ID: 25359865
[TBL] [Abstract][Full Text] [Related]
19. Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions.
Lantuejoul S; Soria JC; Morat L; Lorimier P; Moro-Sibilot D; Sabatier L; Brambilla C; Brambilla E
Clin Cancer Res; 2005 Mar; 11(5):2074-82. PubMed ID: 15756034
[TBL] [Abstract][Full Text] [Related]
20. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
